The World Federation of Hemophilia: 40 years of improving haemophilia care worldwide.
In 2003, the World Federation of Hemophilia marks its 40th anniversary. Established in 1963 by Frank Schnabel, a person with hemophilia from Montreal, Canada, the WFH has grown into its role as an independent, not-for-profit representative of the global haemophilia community. Since then, its biannual world congresses have provided an opportunity to exchange information on research and treatment. Today, more than 3,000 delegates attend these congresses. Until the early 1990s, the WFH's other major function was the International Hemophilia Training Centre programme, offering training fellowships and workshops to medical and paramedical staff from developing countries. In 1982, AIDS was reported in people with haemophilia who had received tainted blood products. The WFH developed task forces and committees to monitor safety and supply issues and set up the Global Forum on the Safety and Supply of Treatment Products. In the mid-1990s, twinning programmes were established for treatment centres and national haemophilia organizations. Twinning facilitates the exchange of training, coaching, and expertise. In the late 1990s, the WFH expanded and began working with local organizations and health authorities in a number of countries to improve the diagnosis and care of persons with hemophilia. The federation currently has ongoing projects in 25 developing countries. On World Hemophilia Day, April 17, 2003, the WFH launched the Global Alliance for Progress (GAP) in haemophilia which aims to double the number of people with haemophilia diagnosed and receiving treatment in up to 40 developing countries over a 10-year period.
Jones
Peter
P
World Federation of Hemophilia, 1425 René Lévesque Boulevard West, Suite 1010, Montreal, Québec, Canada. wfh@wfh.org
Robillard
Line
L
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D003226:Congresses as Topic; D003906:Developing Countries; D005544:Forecasting; D014943:Global Health; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D007391:International Cooperation; D020380:Needs Assessment; D011787:Quality of Health Care; D014944:World Health Organization